Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1985 Dec;40(12):903–909. doi: 10.1136/thx.40.12.903

Plasma histamine concentration during propranolol induced bronchoconstriction.

P W Ind, P J Barnes, M J Brown, C T Dollery
PMCID: PMC460222  PMID: 4095670

Abstract

The mechanism of propranolol induced bronchoconstriction in asthma is uncertain, as airway beta adrenoceptors are not innervated by sympathetic nerves and circulating adrenaline concentrations are not raised. Propranolol 10 mg was infused over 27 minutes in 14 subjects with mild asthma. Peak expiratory flow (PEF) decreased by 80-235 l/min (17-51% of baseline) in nine subjects, who were called "responders," and by less than 50 l/min (12% of baseline) in five "non-responders". These two groups did not differ in baseline ventilatory function or in any clinical characteristic. In "responders" mean PEF had decreased significantly from 440 to 390 l/min after infusion of propranolol 2.1 mg, though the maximum fall in PEF occurred during or within five minutes of the end of the infusion. In nine of the subjects (six "responders" and three "non-responders") the possibility that propranolol induced bronchoconstriction is due to blockade of mast cell beta receptors leading to increased mediator release was examined by measurement of plasma histamine concentration as an index of mast cell degranulation. There was no consistent change in plasma histamine concentration in either group. No evidence of increased mast cell mediator release has been found in association with propranolol induced bronchoconstriction.

Full text

PDF
903

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assem E. S., Schild H. O. Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline. Br J Pharmacol. 1971 Aug;42(4):620–630. doi: 10.1111/j.1476-5381.1971.tb07146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Assem E. S., Schild H. O. Inhibition by sympathomimetic amines of histamine release by antigen in passively sensitized human lung. Nature. 1969 Dec 6;224(5223):1028–1029. doi: 10.1038/2241028a0. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J., Ind P. W., Brown M. J. Plasma histamine and catecholamines in stable asthmatic subjects. Clin Sci (Lond) 1982 Jun;62(6):661–665. doi: 10.1042/cs0620661. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J., Pride N. B. Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects. Br J Clin Pharmacol. 1983 Jun;15(6):677–682. doi: 10.1111/j.1365-2125.1983.tb01549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barnes P., FitzGerald G., Brown M., Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med. 1980 Jul 31;303(5):263–267. doi: 10.1056/NEJM198007313030506. [DOI] [PubMed] [Google Scholar]
  6. Brown M. J., Ind P. W., Causon R., Lee T. H. A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics. J Allergy Clin Immunol. 1982 Jan;69(1 Pt 1):20–24. doi: 10.1016/0091-6749(82)90082-3. [DOI] [PubMed] [Google Scholar]
  7. Coltart D. J., Shand D. G. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man. Br Med J. 1970 Sep 26;3(5725):731–734. doi: 10.1136/bmj.3.5725.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dastur D. K., Manghani D. K., Raghavendran K. V. Distribution and fate of 54Mn in the monkey: studies of differnnt parts of the central nervous system and other organs. J Clin Invest. 1971 Jan;50(1):9–20. doi: 10.1172/JCI106487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FERRIS B. G., Jr, ANDERSON D. O., ZICKMANTEL R. PREDICTION VALUES FOR SCREENING TESTS OF PULMONARY FUNCTION. Am Rev Respir Dis. 1965 Feb;91:252–261. doi: 10.1164/arrd.1965.91.2.252. [DOI] [PubMed] [Google Scholar]
  10. Findlay S. R., Lichtenstein L. M. Basophil "releasability" in patients with asthma. Am Rev Respir Dis. 1980 Jul;122(1):53–59. doi: 10.1164/arrd.1980.122.1.53. [DOI] [PubMed] [Google Scholar]
  11. GOLDMAN H. I., BECKLAKE M. R. Respiratory function tests; normal values at median altitudes and the prediction of normal results. Am Rev Tuberc. 1959 Apr;79(4):457–467. doi: 10.1164/artpd.1959.79.4.457. [DOI] [PubMed] [Google Scholar]
  12. Gauld D. R., Pain M. C., Rubinfeld A. R. Beta-blocking drugs and airways obstruction. Med J Aust. 1979 Jul 28;2(2):88–88. doi: 10.5694/j.1326-5377.1979.tb112725.x. [DOI] [PubMed] [Google Scholar]
  13. Gayrard P., Orehek J., Grimaud C., Charpin J. Beta-adrenergic function in airways of healthy and asthmatic subjects. Thorax. 1975 Dec;30(6):657–662. doi: 10.1136/thx.30.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ind P. W., Barnes P. J., Brown M. J., Causon R., Dollery C. T. Measurement of plasma histamine in asthma. Clin Allergy. 1983 Jan;13(1):61–67. doi: 10.1111/j.1365-2222.1983.tb02568.x. [DOI] [PubMed] [Google Scholar]
  15. Ind P. W., Brown M. J., Lhoste F. J., Macquin I., Dollery C. T. Concentration effect relationships of infused histamine in normal volunteers. Agents Actions. 1982 Apr;12(1-2):12–16. doi: 10.1007/BF01965099. [DOI] [PubMed] [Google Scholar]
  16. KORY R. C., CALLAHAN R., BOREN H. G., SYNER J. C. The Veterans Administration-Army cooperative study of pulmonary function. I. Clinical spirometry in normal men. Am J Med. 1961 Feb;30:243–258. doi: 10.1016/0002-9343(61)90096-1. [DOI] [PubMed] [Google Scholar]
  17. Koëter G. H., Meurs H., de Monchy J. G., de Vries K. Protective effect of disodium cromoglycate on propranolol challenge. Allergy. 1982 Nov;37(8):587–590. doi: 10.1111/j.1398-9995.1982.tb02344.x. [DOI] [PubMed] [Google Scholar]
  18. Lichtenstein L. M., Margolis S. Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science. 1968 Aug 30;161(3844):902–903. doi: 10.1126/science.161.3844.902. [DOI] [PubMed] [Google Scholar]
  19. MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
  20. Orange R. P., Kaliner M. A., Laraia P. J., Austen K. F. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP. Fed Proc. 1971 Nov-Dec;30(6):1725–1729. [PubMed] [Google Scholar]
  21. Raine J. M., Palazzo M. G., Kerr J. H., Sleight P. Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. Br Med J (Clin Res Ed) 1981 Feb 14;282(6263):548–549. doi: 10.1136/bmj.282.6263.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Richardson J. B. Nerve supply to the lungs. Am Rev Respir Dis. 1979 May;119(5):785–802. doi: 10.1164/arrd.1979.119.5.785. [DOI] [PubMed] [Google Scholar]
  23. Ruffin R. E., Frith P. A., Anderton R. C., Kumana C. R., Newhouse M. T., Hargreave F. E. Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):536–540. doi: 10.1002/cpt1979255part1536. [DOI] [PubMed] [Google Scholar]
  24. Schwartz S., Davies S., Juers J. A. Life-threatening cold and exercise-induced asthma potentiated by administration of propranolol. Chest. 1980 Jul;78(1):100–101. doi: 10.1378/chest.78.1.100. [DOI] [PubMed] [Google Scholar]
  25. Strandberg K., Mathé A. A., Yen S. S. Release of histamine and formation of prostaglandins in human lung tissue and rat mast cells. Int Arch Allergy Appl Immunol. 1977;53(6):520–529. doi: 10.1159/000231794. [DOI] [PubMed] [Google Scholar]
  26. Tattersfield A. E., Leaver D. G., Pride N. B. Effects of beta-adrenergic blockade and stimulation on normal human airways. J Appl Physiol. 1973 Nov;35(5):613–619. doi: 10.1152/jappl.1973.35.5.613. [DOI] [PubMed] [Google Scholar]
  27. Townley R. G., McGeady S., Bewtra A. The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects. J Allergy Clin Immunol. 1976 Apr;57(4):358–366. doi: 10.1016/0091-6749(76)90093-2. [DOI] [PubMed] [Google Scholar]
  28. Williams I. P., Millard F. J. Severe asthma after inadvertent ingestion of oxprenolol. Thorax. 1980 Feb;35(2):160–160. doi: 10.1136/thx.35.2.160. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES